(Erstwhile UTI Pharma & Healthcare Fund) Table of Contents The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on Historical performance (Yearly) on absolute basis UTI Healthcare Fund - G
Scheme Objective
CAGR
return of 14.6% since its launch. Ranked 40 in Sectoral
category. . NAV as on 19 Jan 21 ₹142.904 ↑ 1.96 (1.39 %) Net Assets (AUM) as on 30 Nov 2020 ₹610 Cr. Launch Date 28 Jun 1999 Category Equity - Sectoral Rating ☆ Type Open Ended Fund Risk High AMC UTI Asset Management Company Ltd Alpha Ratio 7.26 Expense Ratio 2.59 % Sharpe Ratio 1.548 Information Ratio 0.33 Benchmark Not Available Min Investment ₹5,000 Min SIP Investment ₹500 Exit Load 0-1 Years (1%),1 Years and above(NIL) NAV Price Chart
Returns
Annual Compounded Returns
absolute basis
& more than 1 year are on CAGR (Compound Annual Growth Rate)
basis. as on 19 Jan 21 Duration Returns 1 Month 1.4% 3 Month 10.6% 6 Month 29.7% 1 Year 61.1% 3 Year 16.3% 5 Year 10% 10 Year 15 Year Since launch 14.6% Historical Annual Returns
Year Returns 2020 2019 2018 2017 2016 2015 2014 2013 2012 Growth of 10k Over Years
Date Value 31 Dec 15 ₹10,000 31 Dec 16 ₹9,029 31 Dec 17 ₹9,589 31 Dec 18 ₹8,867 31 Dec 19 ₹8,971 31 Dec 20 ₹15,014 Asset Allocation
Asset Class Value Cash 3.27% Equity 96.73% Sector Allocation
Sector Value Health Care 94.5% Basic Materials 2.22% Top Securities Holdings / Portfolio
Holdings/Securities
Name Global Industry Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMADrug Manufacturers - Specialty & Generic 10% ₹67 Cr 1,132,558
↓ -106,562 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 500124Drug Manufacturers - Specialty & Generic 9% ₹58 Cr 110,782
↓ -3,408 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMADrug Manufacturers - Specialty & Generic 9% ₹58 Cr 624,369
↑ 55,822 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087Drug Manufacturers - General 8% ₹54 Cr 654,227
↑ 15,676 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLABDrug Manufacturers - Specialty & Generic 7% ₹43 Cr 111,549
↓ -13,534 Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | 540596Drug Manufacturers - Specialty & Generic 5% ₹34 Cr 578,554
↑ 88,828 Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 532321Drug Manufacturers - Specialty & Generic 5% ₹32 Cr 667,045
↓ -89,236 Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Jan 20 | NHMedical Care Facilities 4% ₹26 Cr 580,716
↓ -34,154 Biocon Ltd (Healthcare)
Equity, Since 31 Oct 18 | 532523Biotechnology 4% ₹24 Cr 516,118 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 532331Drug Manufacturers - Specialty & Generic 3% ₹23 Cr 137,818
↑ 8,595
Talk to our investment specialistFund Managers
Name Since Tenure V Srivatsa 3 Mar 17 3.83 Yr. Custodians
Company Address Bank of Nova Scotia 12/13, Maker Chamber VI,220, Nariman Point Citibank N.A. India Trent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East), Stock Holding Corporation of India Mittal Court, ‘B’ Wing,,Nariman Point Registrar & Transfer Agent
KFin Technologies Private Limited Address "KARVY HOUSE",46, Avenue 4, Street No.1,,Banjara Hills, FAX 91-40-23311968 Email mailmanager@karvy.com Administrator Companies
Company Address UTI Mutual Fund UTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E) Auditors
Company Address Haribhakti & Co. Chartered Accountants 42, Free Press House,4th Floor,,215, Nariman Point, All Plan & Options
Fund and Plan NAV 6 Month 1 Year 3 Year 5 Year UTI Healthcare Fund
Growth ₹142.904
↑ 1.96 29.66 % 61.07 % 16.31 % 9.98 % UTI Healthcare Fund
Normal Dividend, Payout ₹110.444
↑ 1.52 29.66 % 61.07 % 16.31 % 9.98 % UTI Healthcare Fund
Normal Dividend, Reinvestment ₹110.444
↑ 1.52 29.66 % 61.07 % 16.31 % 9.98 % Data as on 19 Jan 21